Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Gregory T. Lucier, a director at Dentsply Sirona Inc. (NASDAQ:XRAY), recently increased his holdings in the company by purchasing 15,142 shares of common stock. The shares were acquired at a weighted average price of $16.51, totaling approximately $249,994. The purchase comes as the stock trades near its 52-week low of $15.94, having declined 16% in the past week. Following this transaction, Lucier now directly owns 81,971 shares. Additionally, he holds 21,000 shares indirectly through an IRA. This purchase reflects Lucier’s continuing investment in the dental equipment and supplies company, which is headquartered in Charlotte, North Carolina. The $3.18 billion market cap company currently offers a 4% dividend yield and appears undervalued according to InvestingPro analysis. For deeper insights into insider trading patterns and comprehensive financial analysis, explore the detailed Pro Research Report available on InvestingPro.
In other recent news, DENTSPLY SIRONA has reported its fourth-quarter 2024 earnings, revealing a slight beat on earnings per share (EPS) with $0.44 compared to the forecast of $0.43. However, the company fell short on revenue, posting $905 million against the expected $922.82 million, marking a 10.6% decline in reported sales for the quarter. Needham analysts have adjusted their price target for DENTSPLY SIRONA shares from $25.00 to $23.00, maintaining a Buy rating despite the mixed financial outlook for 2025. UBS analyst Kevin Caliendo also reaffirmed a Buy rating, maintaining a price target of $27.00, although noting the market’s negative reaction to the company’s first-quarter guidance.
The company anticipates a high-single-digit percentage organic revenue decline for the first quarter, with flat adjusted EBITDA margin and earnings per share. DENTSPLY SIRONA is exploring strategic alternatives for its Wellspect Healthcare business, aiming to unlock significant value for stakeholders. Digital dentistry remains a focus, with new product launches and increased user engagement. The company expects adjusted EPS between $1.80 and $2.00 for 2025, with strategic initiatives and cost structure optimizations underway to support these goals.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.